Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress

Journal of Immunology

Volumn 181, Issue 7, 2008, Pages 4685-4695

  Rongvaux, Anthony ^a   Galli, Mara ^a   Denanglaire, Sébastien ^a   Van Gool, Frédéric ^a   Drèze, Pierre L ^a   Szpirer, Claude ^a   Bureau, Fabrice ^b   Andris, Fabienne ^a   Leo, Oberdan ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; FK 866; METHYLNITRONITROSOGUANIDINE; MUTANT PROTEIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, MOUSE;

ALLELE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL MATURATION; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC RESISTANCE; GENOTOXICITY; HEMIZYGOSITY; INTRACELLULAR SPACE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN 3T3; CELLULAR IMMUNITY; DRUG EFFECT; ENZYMOLOGY; GENE DELETION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

ANIMALS; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CYTOKINES; GENE DELETION; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; LYMPHOCYTES; METHYLNITRONITROSOGUANIDINE; MICE; MICE, INBRED C57BL; MUTAGENESIS, SITE-DIRECTED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NIH 3T3 CELLS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 58149316660     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.7.4685     Document Type: Article

References (49)

1. Samal, B., Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece. 1994. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol. Cell. Biol. 14: 1431-1437. (Pubitemid 24984261)
2. Shaffer, A. L., A. Rosenwald, E. M. Hurt, J. M. Giltnane, L. T. Lam, O. K. Pickeral, and L. M. Staudt. 2001. Signatures of the immune response. Immunity 15: 375-385.
3. Teague, T. K., D. Hildeman, R. M. Kedl, T. Mitchell, W. Rees, B. C. Schaefer, J. Bender, J. Kappler, and P. Marrack. 1999. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl. Acad. Sci. USA 96: 12691-12696.
4. Feske, S., J. Giltnane, R. Dolmetsch, L. M. Staudt, and A. Rao. 2001. Gene regulation mediated by calcium signals in T lymphocytes. Nat. Immunol. 2: 316-324. (Pubitemid 33706342)
5. Fruman, D. A., G. Z. Ferl, S. S. An, A. C. Donahue, A. B. Satterthwaite, and O. N. Witte. 2002. Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes. Proc. Natl. Acad. Sci. USA 99: 359-364.
6. Xu, L. G., M. Wu, J. Hu, Z. Zhai, and H. B. Shu. 2002. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J. Leukocyte Biol. 72: 410-416.
7. de Fougerolles, A. R., G. Chi-Rosso, A. Bajardi, P. Gotwals, C. D. Green, and V. E. Koteliansky. 2000. Global expression analysis of extracellular matrix-integrin interactions in monocytes. Immunity 13: 749-758.
8. Subrahmanyam, Y. V., S. Yamaga, Y. Prashar, H. H. Lee, N. P. Hoe, Y. Kluger, M. Gerstein, J. D. Goguen, P. E. Newburger, and S. M. Weissman. 2001. RNA expression patterns change dramatically in human neutrophils exposed to bacteria. Blood 97: 2457-2468.
9. Huang, Q., D. Liu, P. Majewski, L. C. Schulte, J. M. Korn, R. A. Young, E. S. Lander, and N. Hacohen. 2001. The plasticity of dendritic cell responses to pathogens and their components. Science 294: 870-875. (Pubitemid 33032108)
10. Perrier, P., F. O. Martinez, M. Locati, G. Bianchi, M. Nebuloni, G. Vago, F. Bazzoni, S. Sozzani, P. Allavena, and A. Mantovani. 2004. Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13. J. Immunol. 172: 7031-7042. (Pubitemid 38669145)
11. Jia, S. H., Y. Li, J. Parodo, A. Kapus, L. Fan, O. D. Rotstein, and J. C. Marshall. 2004. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J. Clin. Invest. 113: 1318-1327.
12. Pilz, S., H. Mangge, B. Obermayer-Pietsch, and W. Marz. 2007. Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions. J. Endocrinol. Invest. 30: 138-144. (Pubitemid 46614445)
13. Stephens, J. M., and A. J. Vidal-Puig. 2006. An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity. Curr. Opin. Lipidol. 17: 128-131.
14. Rongvaux, A., R. J. Shea, M. H. Mulks, D. Gigot, J. Urbain, O. Leo, and F. Andris. 2002. Pre-B-cell colony-enhancing factor, whose expression is upregulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur. J. Immunol. 32: 3225-3234. (Pubitemid 35414880)
15. Revollo, J. R., A. A. Grimm, and S. Imai. 2004. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 279: 50754-50763.
16. Kitani, T., S. Okuno, and H. Fujisawa. 2003. Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS Lett. 544: 74-78. (Pubitemid 36628039)
17. Revollo, J. R., A. Korner, K. F. Mills, A. Satoh, T. Wang, A. Garten, B. Dasgupta, Y. Sasaki, C. Wolberger, R. R. Townsend, et al. 2007. Nampt/PBEF/visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6: 363-375.
18. D'Amours, D., S. Desnoyers, I. D'Silva, and G. G. Poirier. 1999. Poly(ADP-ribosyl) ation reactions in the regulation of nuclear functions. Biochem. J. 342: 249-268. (Pubitemid 29425344)
19. + into a nuclear signal. Genes Dev. 19: 1951-1967.
20. Zong, W. X., D. Ditsworth, D. E. Bauer, Z. Q. Wang, and C. B. Thompson. 2004. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev. 18: 1272-1282.
21. Jagtap, P., and C. Szabo. 2005. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug Discov. 4: 421-440. (Pubitemid 40704125)
22. Virag, L., and C. Szabo. 2002. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54: 375-429.
23. Oliver, F. J., J. Menissier-de Murcia, C. Nacci, P. Decker, R. Andriantsitohaina, S. Muller, G. de la Rubia, J. C. Stoclet, and G. de Murcia. 1999. Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly(ADP-ribose) polymerase-1 deficient mice. EMBO J. 18: 4446-4454.
24. Osoegawa, K., M. Tateno, P. Y. Woon, E. Frengen, A. G. Mammoser, J. J. Catanese, Y. Hayashizaki, and P. J. de Jong. 2000. Bacterial artificial chromosome libraries for mouse sequencing and functional analysis. Genome Res. 10: 116-128. (Pubitemid 30095261)
25. Ventura, A., A. Meissner, C. P. Dillon, M. McManus, P. A. Sharp, L. Van Parijs, R. Jaenisch, and T. Jacks. 2004. Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA 101: 10380-10385. (Pubitemid 38924934)
26. Grignani, F., T. Kinsella, A. Mencarelli, M. Valtieri, D. Riganelli, F. Grignani, L. Lanfrancone, C. Peschle, G. P. Nolan, and P. G. Pelicci. 1998. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 58: 14-19. (Pubitemid 28027708)
27. Naldini, L., U. Blomer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93: 11382-11388. (Pubitemid 26347130)
28. Zerez, C. R., S. J. Lee, and K. R. Tanaka. 1987. Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure. Anal. Biochem. 164: 367-373.
29. De Boer, J., A. Williams, G. Skavdis, N. Harker, M. Coles, M. Tolaini, T. Norton, K. Williams, K. Roderick, A. J. Potocnik, and D. Kioussis. 2003. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33: 314-325. (Pubitemid 36267595)
30. Wosikowski, K., K. Mattern, I. Schemainda, M. Hasmann, B. Rattel, and R. Loser. 2002. WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells. Cancer Res. 62: 1057-1062. (Pubitemid 34160287)
31. Hasmann, M., and I. Schemainda. 2003. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 63: 7436-7442. (Pubitemid 37413486)
32. Virag, L., G. S. Scott, S. Cuzzocrea, D. Marmer, A. L. Salzman, and C. Szabo. 1998. Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly- (ADP-ribose) synthetase (PARS) activation. Immunology 94: 345-355. (Pubitemid 28318599)
33. Wang, Z. Q., L. Stingl, C. Morrison, M. Jantsch, M. Los, K. Schulze-Osthoff, and E. F. Wagner. 1997. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev. 11: 2347-2358.
34. Yu, S. W., H. Wang, M. F. Poitras, C. Coombs, W. J. Bowers, H. J. Federoff, G. G. Poirier, T. M. Dawson, and V. L. Dawson. 2002. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297: 259-263. (Pubitemid 34761289)
35. Schwarzenbacher, R., L. Jaroszewski, F. von Delft, P. Abdubek, E. Ambing, T. Biorac, L. S. Brinen, J. M. Canaves, J. Cambell, H. J. Chiu, et al. 2004. Crystal structure of a type II quinolic acid phosphoribosyltransferase (TM1645) from Thermotoga maritima at 2.50 Å resolution. Proteins 55: 768-771. (Pubitemid 38620100)
36. Khan, J. A., X. Tao, and L. Tong. 2006. Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents. Nat. Struct. Mol. Biol. 13: 582-588.
37. Rongvaux, A., F. Andris, F. Van Gool, and O. Leo. 2003. Reconstructing eukaryotic NAD metabolism. BioEssays 25: 683-690.
38. + depletion and reduced Sir2α deacetylase activity. J. Biol. Chem. 280: 43121-43130.
39. + levels dictate cell survival. Cell 130: 1095-1107.
40. +-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ. Res. 97: 25-34.
41. Van der Veer, E., C. Ho, C. O'Neil, N. Barbosa, R. Scott, S. P. Cregan, and J. G. Pickering. 2007. Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J. Biol. Chem. 282: 10841-10845. (Pubitemid 47100731)
42. Yang, H., S. Lavu, and D. A. Sinclair. 2006. Nampt/PBEF/visfatin: a regulator of mammalian health and longevity? Exp. Gerontol. 41: 718-726. (Pubitemid 44223900)
43. Blander, G., and L. Guarente. 2004. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73: 417-435.
44. Dali-Youcef, N., M. Lagouge, S. Froelich, C. Koehl, K. Schoonjans, and J. Auwerx. 2007. Sirtuins: the "magnificent seven", function, metabolism and longevity. Ann. Med. 39: 335-345. (Pubitemid 47262687)
45. Vaziri, H., S. K. Dessain, E. Ng Eaton, S. I. Imai, R. A. Frye, T. K. Pandita, L. Guarente, and R. A. Weinberg. 2001. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159. (Pubitemid 33035942)
46. Luo, J., A. Y. Nikolaev, S. Imai, D. Chen, F. Su, A. Shiloh, L. Guarente, and W. Gu. 2001. Negative control of p53 by Sir2α promotes cell survival under stress. Cell 107: 137-148.
47. Mostoslavsky, R., K. F. Chua, D. B. Lombard, W. W. Pang, M. R. Fischer, L. Gellon, P. Liu, G. Mostoslavsky, S. Franco, M. M. Murphy, et al. 2006. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124: 315-329. (Pubitemid 43121980)
48. + compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes. J. Neurosci. Res. 85: 3378-3385.
49. Tanaka, M., M. Nozaki, A. Fukuhara, K. Segawa, N. Aoki, M. Matsuda, R. Komuro, and I. Shimomura. 2007. Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. Biochem. Biophys. Res. Commun. 359: 194-201. (Pubitemid 46880493)